RICHMOND, Va., Nov 28, 2005 (BUSINESS WIRE) -- Insmed Incorporated (NASDAQ: INSM) today announced that Philip J. Young, Chief Business Officer of Insmed, will present a corporate overview Tuesday, November 29 at 2:00pm ET during the Lazard Capital Markets Life Sciences Conference taking place in New York. Investors may access a live audio webcast of the presentation via Insmed's corporate website, www.insmed.com. A replay of the presentation will be available for approximately one week.
About Insmed
Insmed is a biopharmaceutical company focused on the discovery and development of drug candidates for the treatment of metabolic diseases and endocrine disorders with unmet medical needs. For more information, please visit http://www.insmed.com.
